MARY GREENWOOD: Open Payments
NPI 1194291112 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,086 in 36 payments from 12 companies in 2025. Trend: 2023 $819 · 2024 $1,507 · 2025 $1,086
Food & beverage: $1,086
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $415 |
| LEO Pharma Inc. | 6 | $154 |
| ABBVIE INC. | 2 | $131 |
| Galderma Laboratories, L.P. | 4 | $79 |
| Lilly USA, LLC | 2 | $57 |
| Janssen Biotech, Inc. | 2 | $52 |
| PFIZER INC. | 3 | $50 |
| Arcutis Biotherapeutics, Inc. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
Products named: DUPIXENT, SKYRIZI, ANZUPGO, NEMLUVIO, TREMFYA, CIBINQO, Zoryve, EBGLYSS.
Industry payments across AZ — which companies pay providers there.
